Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)

• Company Description    agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. Number of Employees: 1,076

• Price / Volume Information    Yesterday's Closing Price: $0.67 Daily Weekly Monthly 20 Day Moving Average: 5,363,755 shares Shares Outstanding: 414.58 (millions) Market Capitalization: $279.26 (millions) Beta: 0.05 52 Week High: $6.08 52 Week Low: $0.51 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.47% -7.49% 12 Week -33.96% -35.15% Year To Date -2.19% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 440 Polaris Parkway Suite 550 - Westerville,OH 43082 USA ph: 562-256-3800 fax: - investors@agilonhealth.com http://agilonhealth.com

• General Corporate Information    Officers Steven J. Sell - Chief Executive Officer and President Ronald A. Williams - Chairman Ravi Sachdev - Vice Chairman Jeffrey Schwaneke - Chief Financial Officer Timothy Gertsch - Chief Accounting Officer Peer Information Agilon Health, Inc. (CHCR) Agilon Health, Inc. (ESRX) Agilon Health, Inc. (MYDP) Agilon Health, Inc. (COR) Agilon Health, Inc. (GBCS) Agilon Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 00857U107 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/24/26 Share - Related Items Shares Outstanding: 414.58 Most Recent Split Date: (:1) Beta: 0.05 Market Capitalization: $279.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 13.34% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.91 Price/Cash Flow: - Price / Sales: 0.05 EPS Growth vs. Year Ago Period: 6.90% vs. Previous Quarter: -8.00% Sales Growth vs. Year Ago Period: -1.08% vs. Previous Quarter: 2.89% ROE 12/31/25 - - 09/30/25 - -75.92 06/30/25 - -66.76 ROA 12/31/25 - - 09/30/25 - -18.35 06/30/25 - -17.47 Current Ratio 12/31/25 - - 09/30/25 - 1.08 06/30/25 - 1.16 Quick Ratio 12/31/25 - - 09/30/25 - 1.08 06/30/25 - 1.16 Operating Margin 12/31/25 - - 09/30/25 - -5.44 06/30/25 - -5.53 Net Margin 12/31/25 - - 09/30/25 - -5.24 06/30/25 - -5.35 Pre-Tax Margin 12/31/25 - - 09/30/25 - -5.46 06/30/25 - -5.55 Book Value 12/31/25 - - 09/30/25 - 0.74 06/30/25 - 0.99 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©